Agilent Technologies AdvanceBio products for analysing biotherapeutics

Wednesday, 08 July, 2015 | Supplied by: Keysight Technologies Australia Pty Ltd


Agilent Technologies has announced two additions to its AdvanceBio family, designed to provide rapid, reproducible results for scientists in the biopharmaceutical industry. The products are designed to deliver results that are easy to reproduce, increasing confidence in their accuracy and completeness.

The AdvanceBio glycan-mapping workflow is a complete consumables workflow for deglycosylation, 2-AB labelling and HILIC glycan analysis using mass spectrometry and fluorescence detection. The workflow features AdvanceBio glycan-mapping columns, glycan standards and N-glycan sample preparation kits, along with all the consumable components researchers require. The product’s comprehensive guides and standard methods provide researchers with everything they need to quickly identify and quantify glycans in a way that is easily reproducible.

The AdvanceBio oligonucleotide column is a high-pH, stable, superficially porous particle-based liquid chromatography column for oligonucleotide analysis. It builds on Agilent’s innovations in superficially porous silica-based columns for biomolecule separations. The right particle design gives researchers the flexibility to use high-performance or ultrahigh-performance liquid chromatography systems. The increased flexibility also allows them to make more efficient use of existing laboratory resources.

Online: www.keysight.com
Phone: 03 9566 1260
Related Products

Beckman Coulter Life Sciences QbD1200+ Total Organic Carbon Analyzer

The product has been designed to make measuring and analysing total organic carbon simple,...

Yokogawa CQ1 benchtop high-throughput 3D confocal imager

The Yokogawa CQ1 benchtop high-throughput 3D confocal imager enables 3D imaging and...

Luxendo InVi SPIM Lattice Pro light sheet microscope for live cell imaging

The Luxendo InVi SPIM Lattice Pro light sheet microscope provides a high level of flexibility for...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd